Therapeutic Asset Ratings
181 results matching 1 filter
129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
MGC026
Non-Small Cell Lung Carcinoma
MacroGenics
P1
C
(37)
Mrtx0902
Non-Small Cell Lung Carcinoma
Mirati Therapeutics Inc.
P1
C
(37)
Mrtx1719
Non-Small Cell Lung Carcinoma
Bristol-Myers Squibb
P1
C
(37)
mt-8421
Non-Small Cell Lung Carcinoma
Molecular Templates, Inc.
P1
C
(37)
ngm438
Non-Small Cell Lung Carcinoma
NGM Biopharmaceuticals, Inc
P1
C
(37)
okn4395
Non-Small Cell Lung Carcinoma
Epkin
P1
C
(37)
Ovm-200
Non-Small Cell Lung Carcinoma
Oxford Vacmedix UK Ltd.
P1
C
(37)
pf-07265028
Non-Small Cell Lung Carcinoma
Pfizer
P1
C
(37)
pf-07921585
Non-Small Cell Lung Carcinoma
Pfizer
P1
C
(37)
P-Muc1C-Allo1 Car-T Cells
Non-Small Cell Lung Carcinoma
Poseida Therapeutics, Inc.
P1
C
(37)
Prth-101
Non-Small Cell Lung Carcinoma
Incendia Therapeutics
P1
C
(37)
Rimiducid
Non-Small Cell Lung Carcinoma
Poseida Therapeutics, Inc.
P1
C
(37)
Rndo-564
Non-Small Cell Lung Carcinoma
Rondo Therapeutics
P1
C
(37)
Tgrx-1942
Non-Small Cell Lung Carcinoma
Shenzhen TargetRx Co., Ltd.
P1
C
(37)
Tolododekin Alfa
Non-Small Cell Lung Carcinoma
Ankyra Therapeutics, Inc
P1
C
(37)
Wm-A1-3389
Non-Small Cell Lung Carcinoma
Wellmarker Bio
P1
C
(37)
zm008
Non-Small Cell Lung Carcinoma
Zumutor Biologics Inc.
P1
C
(37)
INCB 086550
Non-Small Cell Lung Carcinoma
Incyte Corporation
P2
C
(36)
MDM2 INHIBITOR AMG-232
Non-Small Cell Lung Carcinoma
Kartos Therapeutics, Inc.
P1/2
C
(36)
Fosifloxuridine Nafalbenamide
Non-Small Cell Lung Carcinoma
NuCana plc
P1/2
C
(35)
177lu-rad204
Non-Small Cell Lung Carcinoma
Radiopharm Theranostics, Ltd
Early P1
C
(34)
ic9.gd2.car.il-15 t-cells
Non-Small Cell Lung Carcinoma
UNC Lineberger Comprehensive Cancer Center
Early P1
C
(34)
mb1707
Non-Small Cell Lung Carcinoma
Mainline Biosciences, Inc.
Early P1
C
(34)
R130
Non-Small Cell Lung Carcinoma
Shanghai Yunying Medical Technology
Early P1
C
(34)
Nanrilkefusp Alfa
Non-Small Cell Lung Carcinoma
SOTIO Biotech AG
P2
D
(30)
Showing 151 to 175 of 181 assets
Previous
Page 7 of 8
Next